Successful treatment of recurrent focal segmental glomerulosclerosis combined with calcineurin inhibitor nephrotoxicity four yr after kidney transplantation

Clinical Transplantation

Volumn 24, Issue SUPPL. 22, 2010, Pages 48-53

  Mitome, Jun ^a   Yamamoto, Hiroyasu ^a   Maruyama, Yukio ^a   Kobayashi, Akimitsu ^a   Yaginuma, Tatsuhiro ^a   Matsuo, Nanae ^a   Tanno, Yudo ^a   Hayakawa, Hiroshi ^a   Miyazaki, Youichi ^a   Yokoyama, Keitaro ^a   Utsunomiya, Yasunori ^a   Yamaguchi, Yutaka ^b   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcineurin inhibitor toxicity; Low density lipoprotein adsorption; Nephrotic syndrome; Plasmapheresis; Recurrent focal segmental glomerulosclerosis

Indexed keywords

AMLODIPINE BESYLATE; DILTIAZEM; DIPYRIDAMOLE; LOSARTAN POTASSIUM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; CALCINEURIN INHIBITOR; CREATININE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FOCAL GLOMERULOSCLEROSIS; HEADACHE; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; NAUSEA; NEPHROTIC SYNDROME; NEPHROTOXICITY; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SYMPTOM; BLOOD; CHEMICALLY INDUCED; COMPLICATION; DRUG COMBINATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ADULT; CALCINEURIN; COMBINED MODALITY THERAPY; CREATININE; DRUG THERAPY, COMBINATION; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; NEPHROTIC SYNDROME; RECURRENCE; TREATMENT OUTCOME; CALCINEURIN INHIBITORS;

EID: 77954497956     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01266.x     Document Type: Article

References (23)

1. Artero M, Biava C, Amend W. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 1992, 92:375.
2. Andresdottir MB, Ajubi N, Croockweit S. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999, 14:2650.
3. Pardon A, Audard V, Caillard S. Risk factors and outcome of focal and segmental glomeruloscrelosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006, 21:1053.
4. Vincenti F, Ghiggeri GM. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Am J Transplant 2005, 5:1179.
5. Cheigh JS, Mouradian J, Susin M. Kidney transplant nephrotic syndrome: relationship between allograft histopathology and natural course. Kidney Int 1980, 18:358.
6. First MR, Vaidya PN, Maryniak RK. Proteinuria following transplantation. Transplantation 1984, 38:607.
7. Fontaine MP, Rodriguez-Carmona A, Falcon TG. Early proteinuria in renal transplant recipients treated with cyclosporin. Transplantation 1999, 67:561.
8. Kim HC, Park SB, Lee SH. Proteinuria in renal transplant recipients: incidence, cause, and prognostic importance. Transplant Proc 1994, 26:2134.
9. Park JH, Park JH, Bok HJ. Persistent proteinuria as a prognostic factor for determining long-term graft survival in renal transplant recipients. Transplant Proc 2000, 32:1924.
10. Pedi VR, Dean DE, Hariharans S. Proteinuria following renal transplantation: correlation with histopathology and outcome. Transplant Proc 1997, 29:101.
11. Vathsala A, Verani R, Schoenberg L. Proteinuria in cyclosporine-treated renal transplant recipients. Transplantation 1990, 49:35.
12. Yildiz A, Erkoc R, Sever MS. The prognostic importance of severity and type of post-transplant proteinuria. Clin Transplant 1999, 13:241.
13. Choy BY, Chan TM, Lai KN. Recurrent glomerulonephritis after kidney transplantation. Am J Transplant 2006, 6:2535.
14. Abbott KC, Sawyers ES, Oliver JD. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001, 37:366.
15. Crosson JT. Focal segmental glomerulosclerosis and renal transplantation. Transplant Proc 2007, 39:737.
16. Savin VJ, Sharma R, Sharma M. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996, 334:878.
17. Artero ML, Sharma R, Savin VJ. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 1994, 23:574.
18. Deegens JK, Andresdottir MB, Croockewit S. Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl Int 2004, 17:151.
19. Cosio FG, Amer H, Grande JP. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. Transplantation 2007, 83:411.
20. Flechner SM, Kobashigawa J, Klintmalm G. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Clin Transplant 2008, 22:1.
21. Grenda R, Prokurat S, Ciechanowicz A. Evaluation of the genetic background of standard immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients-a retrospective study. Ann Transplant 2009, 14:18.
22. Muso E, Yashiro M, Matsushima M. Does LDL apheresis in steroid-resistant nephrotic syndrome affect prognosis? Nephrol Dial Transplant 1994, 9:257.
23. Muso E, Mune M, Fujii Y. Significantly rapid relief from steroid-resistant nephrotic syndrome by LDL apheresis comnpared with steroid monotherapy. Nephron 2001, 89:408.